Search Results - "Larrey, Edouard"

A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with HCC.

Authors: Larrey, Edouard Campion, Bertille Evain, Manon et al.

Source: Liver International. Dec2022, Vol. 42 Issue 12, p2843-2854. 12p. 1 Diagram, 5 Charts, 2 Graphs.

International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations.

Authors: Cadranel, Jean-François David Ollivier-Hourmand, Isabelle Cadranel, Jacques et al.

Source: BMC Gastroenterology. 9/12/2023, Vol. 23 Issue 1, p1-15. 15p.

ALBI‐based BCLC nomogram: A new or an additional prognostic tool?

Authors: Adhoute, Xavier Larrey, Edouard Pénaranda, Guillaume et al.

Source: Liver International. Jul2020, Vol. 40 Issue 7, p1785-1786. 2p. 1 Graph.

Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.

Authors: Allaire, Manon Campion, Bertille Demory, Alix et al.

Source: Alimentary Pharmacology & Therapeutics. Aug2023, Vol. 58 Issue 3, p346-356. 11p. 5 Charts, 2 Graphs.

Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab.

Authors: Campani, Claudia Bamba‐Funck, Jessica Campion, Bertille et al.

Source: Liver International. Mar2023, Vol. 43 Issue 3, p708-717. 10p. 4 Charts, 3 Graphs.